Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
NEW YORK (Reuters Health) – In patients with stable angina pectoris, the heart-rate lowering drug ivabradine reduces attack frequency and nitrate consumption – and this is true even…
NEW YORK (Reuters Health) – New research suggests that coronary artery calcium score (CACS) and single-photon emission computed tomography (SPECT) provide complimentary information in predicting a person’s short-…
NEW YORK (Reuters Health) – Widespread screening of overweight and obese adults for Cushing’s syndrome is not supported by a new study, even when one or more features…
NEW YORK (Reuters Health) – A central pulse pressure (PP) of 50 mmHg or higher is predictive of future MI, coronary heart disease, and other cardiovascular events, according…
NEW YORK (Reuters Health) – In patients with newly diagnosed multiple myeloma, combining the thalidomide analog lenalidomide with low-dose dexamethasone led to better short-term survival than lenalidomide plus…
NEW YORK (Reuters Health) – Omega-3 fatty acid supplements do not improve the response to sertraline in heart disease patients with major depression, according to results of a…
NEW YORK (Reuters Health) – Adult survivors of childhood cancer, particularly those in poor physical health, are at increased risk for suicidal thoughts, according to an October 19…
NEW YORK (Reuters Health) – A secondary analysis of a previous study provides functional data that further supports the benefits of alteplase therapy when given up to 4.5…
NEW YORK (Reuters Health) – Whether the catheter is removed or not has no bearing on the resolution of catheter-related coagulase-negative staphylococcal bacteremia following treatment with antimicrobial therapy,…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…
